Clinical trial

Tissue Sodium in Pre-hypertensive Patients

NCT02236520

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-09-01

PhasePHASE2

Study timeline

Study start (actual)2014-09-01Date precision: month

Registry last updated2019-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

SpironolactoneDRUG · verified · RxNorm: spironolactone

ChlorthalidoneDRUG · verified · RxNorm: chlorthalidone

DietDIETARY_SUPPLEMENT

PlaceboDRUG

Sponsors & collaborators

Vanderbilt Universitylead sponsor

American Heart Associationcollaborator

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02236520 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.